Description

• • ARA-290 (16mg) is a peptide investigated for its selective activation of tissue-protective receptors.
  • Derived from erythropoietin, it is designed to avoid stimulating red blood cell production.
  • Studied for potential neuroprotective, anti-inflammatory, and tissue-repair effects in research models.
  • Explored in laboratory settings for its role in modulating immune responses and promoting recovery.
  • Commonly utilized in controlled studies focused on nervous system health and cellular resilience.